Showing 701-710 of 7589 results for "".
BONT-A Extends Fillers; Almirall to Acquire Thermi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-bont-a-extends-fillers-almirall-to-acquire-thermi/18648/In this edition of DermWireTV, a look at new data showing that injections with botulinum neurotoxin can extend the efficacy of hyaluronic acid fillers. The American Academy of Dermatology Association offers more response to the USPSTF draft recommendation on the benefits of skin exams for melanoma.Approvals in Psoriasis and Skin Cancer Highlight a Year of Innovation in Skin Disease Management
https://practicaldermatology.com/topics/skin-cancer-photoprotection/approvals-in-psoriasis-and-skin-cancer-highlight-a-year-of-innovation-in-skin-disease-management/21069/After periods of low drug approval rates, the last year brought several new agents to market.Electronic Brachytherapy: Understanding the Technology and Identifying Appropriate Use
https://practicaldermatology.com/topics/practice-management/electronic-brachytherapy-understanding-the-technology-and-identifying-appropriate-use/21148/The following information is for dermatology practices concerning Appropriate Use Criteria (AUC) for Electronic Brachytherapy.Cosmeceuticals Series, Part 2: Antioxidants
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-series-part-2-antioxidants/21395/The second article in this quarterly series examines how cosmeceuticals containing antioxidants can mitigate UV-induced damage.Treating Tear Troughs: Soft Tissue Augmentation
https://practicaldermatology.com/topics/general-topics/treating-tear-troughs-soft-tissue-augmentation/22947/New advancements are emerging in the field of soft tissue augmentation for the treatment of the tear troughs.Take 5: Recent Findings on Bacterial Resistance in Acne Vulgaris
https://practicaldermatology.com/columns/take-5/take-5-recent-findings-on-bacterial-resistance-in-acne-vulgaris/21912/Studies point to new strategies for combating bacterial resistance in the treatment of acne.Understanding PML and Risks Associated with Biologic Therapies
https://practicaldermatology.com/topics/psoriasis/PD0509_10-php/22832/A swarm of controversy has enveloped biologics due to concerns about progressive multifocal leukoencephalopathy.Analyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuNoah Worcester 2024: AAD President Dr. Desai on the AAD
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-desai-aad/24589/Seemal Desai, MD, FAAD, president of the American Academy of Dermatology, summarizes his AAD update presentation at the 2024 Noah Worcester Dermatological Society meeting.Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients
https://practicaldermatology.com/topics/research-update/monoclonal-antibodies-restoring-healthy-skin-microbiome-atopic-dermatitis-patients/24566/Monoclonal Antibodies for Restoring a Healthy Skin Microbiome in Atopic Dermatitis Patients